A team of researchers from four New York institutions have received $6 million from Stand Up to Cancer to address the low participation of Black, Indigenous and People of Color in cancer clinical trials.
As the Galleri test is advancing toward becoming the first multi-cancer detection test to secure FDA approval, cancer care providers are coming up with strategies for using these tests responsibly.
